Anavex Life Sciences Corp. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 28/08/2026 | Mar 2026Filed 28/08/2026 | Dec 2025Filed 09/02/2026 | Jun 2025Filed 28/08/2026 | Mar 2025Filed 28/08/2026 | Dec 2024Filed 09/02/2026 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 13/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $7.8 | −$5.3 | −$5.7 | −$13 | −$11 | −$12 | −$12 | −$11 | |
| $0.08 | −$0.06 | −$0.06 | −$0.16 | −$0.13 | −$0.14 | −$0.14 | −$0.13 | |
| — | 93 | 89 | — | 85 | 85 | 85 | 82 |
Trend